Bronchiolitis ObliteransSymptoms, Doctors, Treatments, Advances & More
Learn About Bronchiolitis Obliterans
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Emory University Hospital
Vibha Lama is an Intensive Care Medicine provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 34 years. Dr. Lama is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Bronchiolitis Obliterans, Bronchitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Lama is board certified in American Board Of Internal Medicine, 2001.
U Of M Pulmonary
John Osterholzer is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Osterholzer is rated as an Elite provider by MediFind in the treatment of Bronchiolitis Obliterans. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Bronchitis, Pulmonary Fibrosis, and Pneumonia. Dr. Osterholzer is board certified in Pulmonary Disease and Critical Care Medicine.
SOFHA Pulmonology
Maria Garcia is a Pulmonary Medicine provider practicing medicine in Johnson City, Tennessee. Dr. Garcia is rated as a Distinguished provider by MediFind in the treatment of Bronchiolitis Obliterans. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, Lung Nodules, and Advanced Bronchoscopy. Dr. Garcia is board certified in American Board Of Internal Medicine.
Summary: The goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS), a form of chronic rejection, after lung transplantation. The main questions it aims to answer are: * Is LAM-001 safe in these patients? * Is LAM-001 effective in slowing BOS progression? Participants will: * Be randomly assigned to inhale...
Summary: This study investigates a type of cell, called abnormal clonogenic epithelial cells, in patients with bronchiolitis obliterans syndrome who have had an donor stem cell transplant or a lung transplant. Learning more about clonogenic cells in these patients may help doctors to detect signs of bronchiolitis obliterans syndrome earlier in future patients.